UGT2B17 (Gene)

Organism:

Homo sapiens

Synonyms:BMND12, ENTREZ:7367, HGNC:12547, MIM:601903, NM_001077, NP_001068, UDP glucuronosyltransferase family 2 member B17, UDPGT2B17, UGT2B17

Omim:OMIM:601903

Id:a538c9ca-3557-5372-8e66-b5761cbed5ce

Hgnc:HGNC:12547

Entrez:7367

Ensembl:ENSG00000197888

Description:UDP glucuronosyltransferase family 2 member B17

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View UGT2B17's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with UGT2B17.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using UGT2B17.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for UGT2B17.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with UGT2B17.

Results found

Linked to

	Label	Description
	GSE178340 carfilzomib MM1.S 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE126463 pomalidomide MM1.S 6 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE178340 1 V 3 CARFILZOMIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE147876 GSE147877 enzalutamide MR42D 2 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE258991 enzalutamide DK1 [Tursiops] 5 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE129698 SYK inhibition 6 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE234637 cytarabine 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE114492 GSE153671 KMT2D inhibition 12 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE125014 enzalutamide prostate gland 6 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE125014 enzalutamide prostate gland 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE178340 carfilzomib MM1.S 1 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE126463 pomalidomide MM1.S 6 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE178340 1 V 3 CARFILZOMIB HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE147876 GSE147877 enzalutamide MR42D 2 v 11 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE258991 enzalutamide DK1 [Tursiops] 5 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE129698 SYK inhibition 6 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE234637 cytarabine 2 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE114492 GSE153671 KMT2D inhibition 12 v 4 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE125014 enzalutamide prostate gland 6 v 4 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE125014 enzalutamide prostate gland 1 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.